Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada · Delayed Price · Currency is CAD

0.9700

-0.0200 (-2.02%)

Jul 31, 2026, 3:56 PM EST

TSXV:EBM Cash Flow Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Income	-0.22	-0.33	-0.46	-0.55	-0.15	-0.6
Depreciation & Amortization	0.02	0.04	0.11	0.11	0.11	0.11
Other Operating Activities	0	0	0.02	0	0	-0.01
Change in Accounts Receivable	-0.06	0.03	-0.03	0	-0.01	0
Change in Accounts Payable	-0.03	0.01	-0.03	0.04	0.01	-0.01
Change in Unearned Revenue	-0	-0.01	-0.06	0.05	0	0.02
Change in Other Net Operating Assets	0.29	0.28	0.42	0.33	0.03	0.38
Operating Cash Flow	0	0.02	-0.02	-0.02	-0	-0.12
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Capital Expenditures	-	-	-	-	-0	-0.01
Investing Cash Flow	-	-	-	-	-0	-0.01

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Short-Term Debt Issued	-	0.02	0.04	0.05	-	-
Long-Term Debt Issued	-	-	-	-	0.06	0.02
Total Debt Issued	0.05	0.02	0.04	0.05	0.06	0.02
Short-Term Debt Repaid	-	-0.02	-0.04	-0.05	-	-
Long-Term Debt Repaid	-	-	-	-	-0.03	-
Total Debt Repaid	-0.06	-0.02	-0.04	-0.05	-0.03	-
Net Debt Issued (Repaid)	-0.01	-0	-0	-0	0.03	0.02
Financing Cash Flow	-0.01	-0	-0	-0	0.03	0.02

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Cash Flow	-0.01	0.02	-0.02	-0.02	0.02	-0.1

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Free Cash Flow	0	0.02	-0.02	-0.02	-0.01	-0.12
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	0.46%	2.47%	-2.17%	-1.95%	-0.56%	-12.41%
Free Cash Flow Per Share	-	-	-	-	-	-0.00
Levered Free Cash Flow	0.11	0.18	0.18	0.18	0.02	0.11
Unlevered Free Cash Flow	0.11	0.19	0.18	0.19	0.02	0.11

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Change in Working Capital	0.2	0.3	0.31	0.42	0.03	0.39